XML 80 R27.htm IDEA: XBRL DOCUMENT v3.20.1
Fair Value Measurement and Fair Value of Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2020
Fair Value, Financial Assets and Liabilities Measured on Recurring and Nonrecurring Basis  
Schedule of financial assets (liabilities) measured at fair value on a recurring basis
The following tables present financial assets and liabilities that are measured at fair value on a recurring basis as of March 31, 2020 and December 31, 2019:
 
($ in thousands)
 
Assets and Liabilities Measured at Fair Value on a Recurring Basis
as of March 31, 2020
 
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Total
Fair Value
AFS debt securities:
 
 
 
 
 
 
 
 
U.S. Treasury securities
 
$
51,428

 
$

 
$

 
$
51,428

U.S. government agency and U.S. government- sponsored enterprise debt securities
 

 
518,408

 

 
518,408

U.S. government agency and U.S. government- sponsored enterprise mortgage-backed securities:
 
 
 
 
 
 
 
 
Commercial mortgage-backed securities
 

 
697,948

 

 
697,948

Residential mortgage-backed securities
 

 
1,352,367

 

 
1,352,367

Municipal securities
 

 
309,626

 

 
309,626

Non-agency mortgage-backed securities:
 
 
 
 
 
 
 
 
Commercial mortgage-backed securities
 

 
87,114

 

 
87,114

Residential mortgage-backed securities
 

 
62,134

 

 
62,134

Corporate debt securities
 

 
10,963

 

 
10,963

Foreign bonds
 

 
284,521

 

 
284,521

Asset-backed securities
 

 
61,556

 

 
61,556

Collateralized loan obligations (“CLOs”)
 

 
259,878

 

 
259,878

Total AFS debt securities
 
$
51,428

 
$
3,644,515

 
$

 
$
3,695,943

 
 
 
 
 
 
 
 
 
Investments in tax credit and other investments:
 
 
 
 
 
 
 
 
Equity securities (1)
 
$
22,195

 
$
8,135

 
$

 
$
30,330

Total investments in tax credit and other investments
 
$
22,195

 
$
8,135

 
$

 
$
30,330

 
 
 
 
 
 
 
 
 
Derivative assets:
 
 
 
 
 
 
 
 
Interest rate contracts
 
$

 
$
605,122

 
$

 
$
605,122

Foreign exchange contracts
 

 
64,383

 

 
64,383

Credit contracts
 

 
8

 

 
8

Equity contracts
 

 
415

 
713

 
1,128

Commodity contracts
 

 
163,563

 

 
163,563

Gross derivative assets
 
$

 
$
833,491

 
$
713

 
$
834,204

Netting adjustments (2)
 
$

 
$
(178,774
)
 
$

 
$
(178,774
)
Net derivative assets
 
$

 
$
654,717

 
$
713

 
$
655,430

 
 
 
 
 
 
 
 
 
Derivative liabilities:
 
 
 
 
 
 
 
 
Interest rate contracts
 
$

 
$
403,351

 
$

 
$
403,351

Foreign exchange contracts
 

 
55,658

 

 
55,658

Credit contracts
 

 
218

 

 
218

Commodity contracts
 

 
199,288

 

 
199,288

Gross derivative liabilities
 
$

 
$
658,515

 
$

 
$
658,515

Netting adjustments (2)
 
$

 
$
(243,101
)
 
$

 
$
(243,101
)
Net derivative liabilities
 
$

 
$
415,414

 
$

 
$
415,414

 
(1)
Equity securities consist of mutual funds with readily determinable fair values.
(2)
Represents balance sheet netting of derivative assets and liabilities and related cash collateral under master netting agreements or similar agreements. See Note 6Derivatives to the Consolidated Financial Statements in this Form 10-Q for additional information.
 
($ in thousands)
 
Assets and Liabilities Measured at Fair Value on a Recurring Basis
as of December 31, 2019
 
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Total
Fair Value
AFS debt securities:
 
 
 
 
 
 
 
 
U.S. Treasury securities
 
$
176,422

 
$

 
$

 
$
176,422

U.S. government agency and U.S. government- sponsored enterprise debt securities
 

 
581,245

 

 
581,245

U.S. government agency and U.S. government- sponsored enterprise mortgage-backed securities:
 
 
 
 
 
 
 


Commercial mortgage-backed securities
 

 
603,471

 

 
603,471

Residential mortgage-backed securities
 

 
1,003,897

 

 
1,003,897

Municipal securities
 

 
102,302

 

 
102,302

Non-agency mortgage-backed securities:
 
 
 
 
 
 
 
 
Commercial mortgage-backed securities
 

 
88,550

 

 
88,550

Residential mortgage-backed securities
 

 
46,548

 

 
46,548

Corporate debt securities
 

 
11,149

 

 
11,149

Foreign bonds
 

 
354,172

 

 
354,172

Asset-backed securities
 

 
64,752

 

 
64,752

CLOs
 

 
284,706

 

 
284,706

Total AFS debt securities
 
$
176,422

 
$
3,140,792

 
$

 
$
3,317,214

 
 
 
 
 
 
 
 
 
Investments in tax credit and other investments:
 
 
 
 
 
 
 
 
Equity securities (1)
 
$
21,746

 
$
9,927

 
$

 
$
31,673

Total investments in tax credit and other investments
 
$
21,746

 
$
9,927

 
$

 
$
31,673

 
 
 
 
 
 
 
 
 
Derivative assets:
 
 
 
 
 
 
 
 
Interest rate contracts
 
$

 
$
192,883

 
$

 
$
192,883

Foreign exchange contracts
 

 
54,637

 

 
54,637

Credit contracts
 

 
2

 

 
2

Equity contracts
 

 
993

 
421

 
1,414

Commodity contracts
 

 
81,380

 

 
81,380

Gross derivative assets
 
$

 
$
329,895

 
$
421

 
$
330,316

Netting adjustments (2)
 
$

 
$
(125,319
)
 
$

 
$
(125,319
)
Net derivative assets
 
$

 
$
204,576

 
$
421

 
$
204,997

 
 
 
 
 
 
 
 
 
Derivative liabilities:
 
 
 
 
 
 
 
 
Interest rate contracts
 
$

 
$
127,317

 
$

 
$
127,317

Foreign exchange contracts
 

 
48,610

 

 
48,610

Credit contracts
 

 
84

 

 
84

Commodity contracts
 

 
80,517

 

 
80,517

Gross derivative liabilities
 
$

 
$
256,528

 
$

 
$
256,528

Netting adjustments (2)
 
$

 
$
(159,799
)
 
$

 
$
(159,799
)
Net derivative liabilities
 
$

 
$
96,729

 
$

 
$
96,729

 

(1)
Equity securities consist of mutual funds with readily determinable fair values.
(2)
Represents balance sheet netting of derivative assets and liabilities and related cash collateral under master netting agreements or similar agreements. See Note 6Derivatives to the Consolidated Financial Statements in this Form 10-Q for additional information.
Reconciliation of the beginning and ending balances for equity warrants measured at fair value on a recurring basis using significant unobservable inputs (Level 3) The following table provides a reconciliation of the beginning and ending balances of these equity warrants for the three months ended March 31, 2020 and 2019:
 
($ in thousands)
 
Three Months Ended March 31,
 
2020
 
2019
Equity Contracts
 
 
 
 
Beginning balance
 
$
421

 
$
673

Total gains (losses) included in earnings (1)
 
292

 
(231
)
Ending balance

$
713

 
$
442

 

(1)
Includes unrealized gains (losses) of $292 thousand and $(43) thousand for the three months ended March 31, 2020 and 2019, respectively. The realized/unrealized gains (losses) of equity warrants are included in Lending fees on the Consolidated Statement of Income.

Schedule of carrying amounts of assets that were still held and had fair value changes measured on a nonrecurring basis
The following tables present the carrying amounts of assets that were still held and had fair value changes measured on a nonrecurring basis as of March 31, 2020 and December 31, 2019:
 
($ in thousands)
 
Assets Measured at Fair Value on a Nonrecurring Basis
as of March 31, 2020
 
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Fair Value
Measurements
Impaired loans (1):
 
 
 
 
 
 
 
 
Commercial:
 
 
 
 
 
 
 
 
C&I
 
$

 
$

 
$
28,877

 
$
28,877

CRE:
 
 
 
 
 
 
 
 
CRE
 

 

 
735

 
735

Total commercial
 

 

 
29,612

 
29,612

Consumer:
 
 
 
 
 
 
 
 
Residential mortgage:
 
 
 
 
 
 
 
 
HELOCs
 

 

 
1,798

 
1,798

Other consumer
 

 

 
2,491

 
2,491

Total consumer
 

 

 
4,289

 
4,289

Total impaired loans
 
$

 
$

 
$
33,901

 
$
33,901

Investments in tax credit and other investments, net
 
$

 
$

 
$
3,076

 
$
3,076

Other nonperforming assets
 
$

 
$

 
$
867

 
$
867

 
 
($ in thousands)
 
Assets Measured at Fair Value on a Nonrecurring Basis
as of December 31, 2019
 
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Fair Value
Measurements
Non-PCI impaired loans:
 
 
 
 
 
 
 
 
Commercial:
 
 
 
 
 
 
 
 
C&I
 
$

 
$

 
$
47,554

 
$
47,554

CRE:
 
 
 
 
 
 
 
 
CRE
 

 

 
753

 
753

Total commercial
 

 

 
48,307

 
48,307

Consumer:
 
 
 
 
 
 
 
 
Residential mortgage:
 
 
 
 
 
 
 
 
HELOCs
 

 

 
1,372

 
1,372

Total consumer
 

 

 
1,372

 
1,372

Total non-PCI impaired loans
 
$

 
$

 
$
49,679

 
$
49,679

OREO (2)
 
$

 
$

 
$
125

 
$
125

Investments in tax credit and other investments, net
 
$

 
$

 
$
3,076

 
$
3,076

 

(1)
The Company adopted ASU 2016-13 using the prospective transition approach for PCD loans that were previously accounted for as PCI loans. Total impaired loans as of March 31, 2020 considers PCD loans, if impaired, whereas the impaired loans as of December 31, 2019 includes only non-PCI loans.
(2)
Amounts are included in Other assets on the Consolidated Balance Sheet and represent the carrying value of OREO properties that were written down subsequent to their initial classification as OREO.
Schedule of increase (decrease) in fair value of assets for which a fair value adjustment has been recognized, nonrecurring basis
The following table presents the increase (decrease) in fair value of assets for which a fair value adjustment has been recognized for the three months ended March 31, 2020 and 2019, related to assets that were still held as of those dates:
 
($ in thousands)
 
Three Months Ended March 31,
 
2020
 
2019
Impaired loans:
 
Total Impaired Loans (1)
 
Non-PCI Impaired Loans
Commercial:
 
 
 
 
C&I
 
$
(21,501
)
 
$
(2,734
)
CRE:
 
 
 
 
CRE
 
(5
)
 
2

Total commercial
 
(21,506
)
 
(2,732
)
Consumer:
 
 
 
 
Residential mortgage:
 
 
 
 
HELOCs
 
(193
)
 
(78
)
Other consumer
 
2,491

 

Total consumer
 
2,298

 
(78
)
Total impaired loans
 
$
(19,208
)
 
$
(2,810
)
Investments in tax credit and other investments, net
 
$
150

 
$
(6,978
)
Other nonperforming assets
 
$
(300
)
 
$

 

(1)
The Company adopted ASU 2016-13 using the prospective transition approach for PCD loans that were previously accounted for as PCI loans. Total impaired loans during the three months ended March 31, 2020 considers PCD loans, if impaired, whereas impaired loans during the three months ended March 31, 2019 includes only non-PCI loans.
Schedule of the carrying and fair value estimates per the fair value hierarchy of financial instruments measured on a nonrecurring basis
The following tables present the fair value estimates for financial instruments as of March 31, 2020 and December 31, 2019, excluding financial instruments recorded at fair value on a recurring basis as they are included in the tables presented elsewhere in this Note. The carrying amounts in the following tables are recorded on the Consolidated Balance Sheet under the indicated captions, except for accrued interest receivable and mortgage servicing rights that are included in Other assets, and accrued interest payable that is included in Accrued expenses and other liabilities. These financial assets and liabilities are measured at amortized cost basis on the Company’s Consolidated Balance Sheet.
 
($ in thousands)
 
March 31, 2020
 
Carrying
Amount
 
Level 1
 
Level 2
 
Level 3
 
Estimated
Fair Value
Financial assets:
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
3,080,042

 
$
3,080,042

 
$

 
$

 
$
3,080,042

Interest-bearing deposits with banks
 
$
293,509

 
$

 
$
293,509

 
$

 
$
293,509

Resale agreements (1)
 
$
860,000

 
$

 
$
867,872

 
$

 
$
867,872

Restricted equity securities, at cost
 
$
78,745

 
$

 
$
78,745

 
$

 
$
78,745

Loans held-for-sale
 
$
1,594

 
$

 
$
1,594

 
$

 
$
1,594

Loans held-for-investment, net
 
$
35,336,390

 
$

 
$

 
$
35,736,331

 
$
35,736,331

Mortgage servicing rights
 
$
5,711

 
$

 
$

 
$
7,926

 
$
7,926

Accrued interest receivable
 
$
148,294

 
$

 
$
148,294

 
$

 
$
148,294

Financial liabilities:
 
 
 
 
 
 
 
 
 
 
Demand, checking, savings and money market deposits
 
$
28,720,425

 
$

 
$
28,720,425

 
$

 
$
28,720,425

Time deposits
 
$
9,966,533

 
$

 
$
9,992,060

 
$

 
$
9,992,060

Short-term borrowings
 
$
66,924

 
$

 
$
66,924

 
$

 
$
66,924

FHLB advances
 
$
646,336

 
$

 
$
657,859

 
$

 
$
657,859

Repurchase agreements (1)
 
$
450,000

 
$

 
$
470,230

 
$

 
$
470,230

Long-term debt
 
$
147,169

 
$

 
$
152,942

 
$

 
$
152,942

Accrued interest payable
 
$
25,209

 
$

 
$
25,209

 
$

 
$
25,209

 
 
($ in thousands)
 
December 31, 2019
 
Carrying
Amount
 
Level 1
 
Level 2
 
Level 3
 
Estimated
Fair Value
Financial assets:
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
3,261,149

 
$
3,261,149

 
$

 
$

 
$
3,261,149

Interest-bearing deposits with banks
 
$
196,161

 
$

 
$
196,161

 
$

 
$
196,161

Resale agreements (1)
 
$
860,000

 
$

 
$
856,025

 
$

 
$
856,025

Restricted equity securities, at cost
 
$
78,580

 
$

 
$
78,580

 
$

 
$
78,580

Loans held-for-sale
 
$
434

 
$

 
$
434

 
$

 
$
434

Loans held-for-investment, net
 
$
34,420,252

 
$

 
$

 
$
35,021,300

 
$
35,021,300

Mortgage servicing rights
 
$
6,068

 
$

 
$

 
$
8,199

 
$
8,199

Accrued interest receivable
 
$
144,599

 
$

 
$
144,599

 
$

 
$
144,599

Financial liabilities:
 
 
 
 
 
 
 
 
 
 
Demand, checking, savings and money market deposits
 
$
27,109,951

 
$

 
$
27,109,951

 
$

 
$
27,109,951

Time deposits
 
$
10,214,308

 
$

 
$
10,208,895

 
$

 
$
10,208,895

Short-term borrowings
 
$
28,669

 
$

 
$
28,669

 
$

 
$
28,669

FHLB advances
 
$
745,915

 
$

 
$
755,371

 
$

 
$
755,371

Repurchase agreements (1)
 
$
200,000

 
$

 
$
232,597

 
$

 
$
232,597

Long-term debt
 
$
147,101

 
$

 
$
152,641

 
$

 
$
152,641

Accrued interest payable
 
$
27,246

 
$

 
$
27,246

 
$

 
$
27,246

 
(1)
Resale and repurchase agreements are reported net pursuant to ASC 210-20-45-11, Balance Sheet Offsetting: Repurchase and Reverse Repurchase Agreements. Out of gross repurchase agreements of $450.0 million, $0.0 million and $250.0 million as of March 31, 2020 and December 31, 2019, respectively, were eligible for netting against gross resale agreements
Fair Value, Measurements, Recurring  
Fair Value, Financial Assets and Liabilities Measured on Recurring and Nonrecurring Basis  
Schedule of quantitative information about significant unobservable inputs used in the valuation of Level 3 fair value measurements
The following table presents quantitative information about the significant unobservable inputs used in the valuation of Level 3 fair value measurements as of March 31, 2020 and December 31, 2019, respectively. The significant unobservable inputs presented in the table below are those that the Company considers significant to the fair value of the Level 3 assets. The Company considers unobservable inputs to be significant if, by their exclusion, the fair value of the Level 3 assets would be impacted by a predetermined percentage change.
 
($ in thousands)
 
Fair Value
Measurements
(Level 3)
 
Valuation
Technique
 
Unobservable
Inputs
 
Range of Inputs
 
Weighted-
Average (1)
March 31, 2020
 
 
 
 
 
 
 
 
 
 
Derivative assets:
 
 
 
 
 
 
 
 
 
 
Equity contracts
 
$
713

 
Black-Scholes option pricing model
 
Equity volatility
 
72% — 86%
 
82%
 
 
 
 
 
 
Liquidity discount
 
47%
 
47%
December 31, 2019
 
 
 
 
 
 
 
 
 
 
Derivative assets:
 
 
 
 
 
 
 
 
 
 
Equity contracts
 
$
421

 
Black-Scholes option pricing model
 
Equity volatility
 
39% — 44%
 
42%
 
 
 
 
 
 
Liquidity discount
 
47%
 
47%
 
(1)
Weighted-average is calculated based on fair value of equity warrants as of March 31, 2020 and December 31, 2019.
Fair Value, Measurements, Nonrecurring  
Fair Value, Financial Assets and Liabilities Measured on Recurring and Nonrecurring Basis  
Schedule of quantitative information about significant unobservable inputs used in the valuation of Level 3 fair value measurements
The following table presents the quantitative information about the significant unobservable inputs used in the valuation of Level 3 fair value measurements that are measured on a nonrecurring basis as of March 31, 2020 and December 31, 2019:
 
($ in thousands)
 
Fair Value
Measurements
(Level 3)
 
Valuation
Technique(s)
 
Unobservable
Input(s)
 
Range of 
Input(s)
 
Weighted-
Average (1)
March 31, 2020
 
 
 
 
 
 
 
 
 
 
Impaired loans (1)
 
$
25,140

 
Discounted cash flows
 
Discount
 
4% — 15%
 
12%
 
 
$
5,712

 
Fair value of collateral
 
Discount
 
8% — 9%
 
9%
 
 
$
2,491

 
Fair value of collateral
 
Contract value
 
NM
 
NM
 
 
$
558

 
Fair value of property
 
Selling cost
 
8%
 
8%
Other nonperforming assets
 
$
867

 
Fair value of collateral
 
Contract value
 
NM
 
NM
Investments in tax credit and other investments, net
 
$
3,076

 
Individual analysis of each investment
 
Expected future tax benefits and distributions
 
NM
 
NM
December 31, 2019
 
 
 
 
 
 
 
 
 
 
Non-PCI impaired loans
 
$
27,841

 
Discounted cash flows
 
Discount
 
4% — 15%
 
14%
 
 
$
1,014

 
Fair value of collateral
 
Discount
 
8% — 20%
 
19%
 
 
$
20,824

 
Fair value of collateral
 
Contract value
 
NM
 
NM
OREO
 
$
125

 
Fair value of property
 
Selling cost
 
8%
 
8%
Investments in tax credit and other investments, net
 
$
3,076

 
Individual analysis of each investment
 
Expected future tax benefits and distributions
 
NM
 
NM
 
NM — Not meaningful.
(1)
Presented on a total impaired loan basis due to the adoption of ASU 2016-13 PCD loans (formerly, PCI loans) are assessed for impairment in the same manner as non-PCD loans.
(2)
Weighted-average is based on the relative fair value of the respective assets as of March 31, 2020 and December 31, 2019.